TimesSquare Capital Management LLC Takes $354,000 Position in Humana Inc. (NYSE:HUM)

TimesSquare Capital Management LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 844 shares of the insurance provider’s stock, valued at approximately $354,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Graves Light Private Wealth Management Inc. purchased a new stake in shares of Humana during the 4th quarter valued at about $27,000. SRS Capital Advisors Inc. grew its stake in shares of Humana by 322.2% during the 4th quarter. SRS Capital Advisors Inc. now owns 76 shares of the insurance provider’s stock valued at $31,000 after acquiring an additional 58 shares during the period. First Horizon Advisors Inc. bought a new position in shares of Humana during the 4th quarter valued at approximately $31,000. Childress Capital Advisors LLC bought a new position in shares of Humana during the 4th quarter valued at approximately $33,000. Finally, Jacobi Capital Management LLC grew its stake in shares of Humana by 271.4% during the 1st quarter. Jacobi Capital Management LLC now owns 78 shares of the insurance provider’s stock valued at $33,000 after acquiring an additional 57 shares during the period. 92.11% of the stock is owned by hedge funds and other institutional investors.

In other news, insider Timothy Alan Wheatley sold 8,508 shares of the stock in a transaction that occurred on Monday, May 3rd. The stock was sold at an average price of $450.59, for a total transaction of $3,833,619.72. Following the completion of the transaction, the insider now directly owns 11,494 shares of the company’s stock, valued at approximately $5,179,081.46. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Christopher H. Hunter sold 5,156 shares of the stock in a transaction that occurred on Thursday, April 29th. The stock was sold at an average price of $443.76, for a total value of $2,288,026.56. Following the transaction, the insider now directly owns 8,653 shares of the company’s stock, valued at $3,839,855.28. The disclosure for this sale can be found here. 0.40% of the stock is owned by corporate insiders.

HUM has been the subject of several recent analyst reports. Wells Fargo & Company initiated coverage on Humana in a research note on Monday, May 24th. They issued an “equal weight” rating and a $472.00 price target for the company. Zacks Investment Research cut Humana from a “hold” rating to a “sell” rating and set a $447.00 price objective on the stock. in a report on Tuesday, March 30th. Citigroup upped their price objective on Humana from $496.00 to $510.00 in a report on Thursday, April 29th. Oppenheimer upped their price objective on Humana from $460.00 to $480.00 and gave the stock an “outperform” rating in a report on Thursday, April 29th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell increased their price target on Humana from $496.00 to $510.00 and gave the company a “buy” rating in a report on Thursday, April 29th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and ten have assigned a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $469.00.

NYSE:HUM opened at $420.96 on Friday. The business’s 50-day simple moving average is $437.99. The firm has a market cap of $54.31 billion, a PE ratio of 14.97, a P/E/G ratio of 1.46 and a beta of 0.88. Humana Inc. has a 1 year low of $365.06 and a 1 year high of $475.44. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.43.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 28th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.21 by $0.46. The firm had revenue of $20.67 billion during the quarter, compared to analysts’ expectations of $20.42 billion. Humana had a return on equity of 19.08% and a net margin of 4.72%. The business’s revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the firm earned $5.40 EPS. As a group, research analysts forecast that Humana Inc. will post 21.64 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 30th. Shareholders of record on Wednesday, June 30th will be paid a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.67%. The ex-dividend date is Tuesday, June 29th. Humana’s dividend payout ratio is presently 14.93%.

Humana Company Profile

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: How to Trade Using Analysts Ratings

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.